SynopsisNasal Spray Live Attenuated Influenza Vaccine (LAIV), often marketed under the brand name FluMist, is a type of influenza vaccine designed to protect against the influenza virus. Unlike traditional injectable influenza vaccines, which contain inactivated (kill.....
SynopsisRivastigmine is in a class of medications called cholinesterase inhibitors. It improves mental function (such as memory and thinking) by increasing the amount of a certain natural substance in the brain. Rivastigmine is used to treat mild to moderate dementia .....
SynopsisAchondroplasia is a disorder of bone growth that prevents the changing of cartilage (particularly in the long bones of the arms and legs) to bone. It is characterized by dwarfism, limited range of motion at the elbows, large head size (macrocephaly), small fin.....
SynopsisThe global Breast Lesion Localization Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Breast Lesion Localization Devi.....
Synopsis Chemotherapy induced nausea and vomiting (CINV) drugs refer to medication or treatment that is offered to cancer patients who experience nausea and vomiting due to chemotherapy. The classification of Chemotherapy Induced Nausea and Vomit.....
SynopsisMass spectrometry is an analytic technique with high specificity and a growing presence in laboratory medicine. Various types of mass spectrometers are being used in an increasing number of clinical laboratories around the world, and, as a result, significant .....
Synopsis Highlights The global Vitamin Syrup market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028. North American market for Vitamin Syrup is estimated .....
SynopsisEndoscopy bite block is a device inserted into a patient's mouth during endoscopic procedures to protect the scope and prevent the patient from biting down on it. The global Endoscopy Bite Block market was valued at US$ million in 2023 and is anticipated.....
SynopsisThe global Immunoassay Interference Blocker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for Immunoassay Interference Blocker .....
SynopsisThe global Ertapenem API market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAG.....
